Elix, Inc. (CEO: Shinya Yuki / HQ: Tokyo, hereinafter "Elix"), an AI drug discovery company with the mission of "Rethinking Drug Discovery", today announced that it has entered into a drug discovery ...

PRISM BioLab , today announced that it has entered into a drug discovery collaboration with Elix, effective April 1, 2025.

Researchers have developed a pioneering, sustainable method for producing cadmium-based quantum dots (QDs) in water using a biocompatible chalcogen source. This fully aqueous, continuous flow process ...

The robust vendor analysis is designed to help clients improve their market position. This report provides a detailed analysis of several leading market vendors in Saudi Arabia, and includes ...

Collagen and biotin are popular supplements known for their hair and skin health benefits. Learn which is better, how to take ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

Hyderabad: Granules India Limited has announced the successful closing of the acquisition of Senn Chemicals AG, a Swiss based ...

Granules India completes aquisition of Swiss- based CDMO, Senn Chemicals: Our Bureau, Mumbai Friday, April 11, 2025, 12:10 ...

With Senn's expertise and infrastructure, Granules aims to scale up its innovation capabilities and diversify its portfolio into complex and next-gen therapeutics.

Granules India Limited on Thursday announced the successful acquisition of Senn Chemicals AG, a Swiss-based Contract Development and Manufacturing Organization (CDMO) specializing in peptide ...